References
- 1. . Real-world evidence of mesenchymal stem cell therapy in knee osteoarthritis: a large prospective two-year case series. Regen. Med. 17(6), 355–373 (2022).
- 2. . Analysis of GMP for marketing authorization of ATMPs: comparison in the US, the EU, Japan and South Korea. Regen. Med. 17(5), 283–297 (2022).
- 3. . Industry updates from the field of stem cell research and regenerative medicine in January 2022. Regen. Med. 17(5), 245–253 (2022).
- 4. . Mending the gaps: ethically sensitive cells and the evolution of European stem cell policy. Regen. Med. 17(8), 581–595 (2022).
- 5. . Industry updates from the field of stem cell research and regenerative medicine in February 2022. Regen. Med. 17(6), 327–336 (2022).
- 6. . Online seminars as an information source for direct-to-consumer stem cell therapy. Regen. Med. 17(2), 81–90 (2022).
- 7. Characterization and bioassays of extracellular vesicles extracted by tangential flow filtration. Regen. Med. 17(3), 141–154 (2022).
- 8. . Research progress in seed cells for cartilage tissue engineering. Regen. Med. 17(9), 659–675 (2022).
- 9. . Current challenges of retinal ganglion cell regeneration. Regen. Med. 17(4), 199–201 (2022).
- 10. RegMedNet. www.regmednet.com
- 11. RegMedNet Technology digest: non-viral vectors. www.regmednet.com/technology-digest-non-viral-vectors/
- 12. . Technology digest: non-viral vectors. Regen. Med. 17(11), 789–791 (2022).
- 13. RegMedNet. RegMedNet Rising Star Award 2022. www.regmednet.com/regmednet-rising-star-award-2022-and-the-winner-is/
- 14. RegMedNet. Overcoming the global donor shortage with tissue-engineered corneas. www.regmednet.com/webinars/overcoming-the-global-donor-shortage-with-tissue-engineered-corneas/
- 15. Regen Med Twitter page. www.twitter.com/Regen_Med
- 16. LinkedIn Group Regenerative Medicine. www.linkedin.com/groups/4383090/
- 17. Future Science Group. Future Medicine Author Guidelines. www.futuremedicine.com/authorguide